The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

ludc webb

Hanna Markstad

Doctoral student

ludc webb

The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used

Author

  • Jonas Jögi
  • Hanna Markstad
  • Ellen Tufvesson
  • Leif Bjermer
  • Marika Bajc

Summary, in English

Ventilation/perfusion (V/P) single-photon emission computed tomography (SPECT) is recognized as a diagnostic method with potential beyond the diagnosis of pulmonary embolism. V/P SPECT identifies functional impairment in diseases such as heart failure (HF), pneumonia, and chronic obstructive pulmonary disease (COPD). The development of hybrid SPECT/computed tomography (CT) systems, combining functional with morphological imaging through the addition of low-dose CT (LDCT), may be useful in COPD, as these patients are prone to lung cancer and other comorbidities. The aim of this study was to investigate the added value of LDCT among healthy smokers and patients with stable COPD, when examined with V/P SPECT/CT hybrid imaging. Sixty-nine subjects, 55 with COPD (GOLD I-IV) and 14 apparently healthy smokers, were examined with V/P SPECT and LDCT hybrid imaging. Spirometry was used to verify COPD grade. Only one apparently healthy smoker and three COPD patients had a normal or nearly normal V/P SPECT. All other patients showed various degrees of airway obstruction, even when spirometry was normal. The same interpretation was reached on both modalities in 39% of the patients. LDCT made V/P SPECT interpretation more certain in 9% of the patients and, in 52%, LDCT provided additional diagnoses. LDCT better characterized the type of emphysema in 12 patients. In 19 cases, tumor-suspected changes were reported. Three of these 19 patients (ie, 4.3% of all subjects) were in the end confirmed to have lung cancer. The majority of LDCT findings were not regarded as clinically significant. V/P SPECT identified perfusion patterns consistent with decompensated left ventricular HF in 14 COPD patients. In 16 patients (23%), perfusion defects were observed. HF and perfusion defects were not recognized with LDCT. In COPD patients and long-time smokers, hybrid imaging had added value compared to V/P SPECT alone, by identifying patients with lung malignancy and more clearly identifying emphysema. V/P SPECT visualizes comorbidities to COPD not seen with LDCT, such as pulmonary embolism and left ventricular HF.

Department/s

  • EpiHealth: Epidemiology for Health
  • Clinical Physiology (Lund)
  • Cardiovascular Research - Epidemiology
  • Lung physiology and biomarkers
  • Respiratory Medicine, Allergology, and Palliative Medicine

Publishing year

2015

Language

English

Pages

25-30

Publication/Series

The International Journal of Chronic Obstructive Pulmonary Disease

Volume

10

Document type

Journal article

Publisher

Dove Press

Topic

  • Cardiac and Cardiovascular Systems
  • Respiratory Medicine and Allergy

Keywords

  • lung
  • lung cancer
  • V/P SPECT
  • ventilation/perfusion
  • single-photon
  • emission computed tomography
  • computed tomography

Status

Published

Research group

  • Cardiovascular Research - Epidemiology
  • Lung physiology and biomarkers

ISBN/ISSN/Other

  • ISSN: 1178-2005